The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning

British Journal of Radiology

Volumn 87, Issue 1042, 2014, Pages

  Alobaidli, S ^a   McQuaid, S ^b   South, C ^b   Prakash, V ^c   Evans, P ^a   Nisbet, A ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; IMAGE ANALYSIS; IMAGING; MOTION ANALYSIS SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RESPIRATORY GATED IMAGING; REVIEW; STATISTICAL ANALYSIS; SURVIVAL PREDICTION; SYNDROME DELINEATION; TEXTURE ANALYSIS; TREATMENT OUTCOME; TREATMENT PLANNING; COMPUTER ASSISTED RADIOTHERAPY; DIAGNOSTIC IMAGING; HUMAN; NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; RADIOGRAPHY;

DIAGNOSTIC IMAGING; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84907486549     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140369     Document Type: Review

References (70)

1. De Ruysscher D, Nestle U, Jeraj R, MacManus M. PET scans in radiotherapy planning of lung cancer. Lung Cancer 2012; 75: 141-5. doi: 10.1016/j.lungcan.2011.07.018
2. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92. doi: 10.1056/NEJMoa1113205
3. American Joint Committee on Cancer (AJCC). Cancer staging references. Available from: https://cancerstaging.org/referencestools/Pages/What-is-Cancer-Staging.aspx
4. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A 2000; 97: 9226-33.
5. Brun E, Kjellén E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002; 24: 127-35.
6. Hicks RJ, Mac Manus MP, Matthews JP, Hogg A, Binns D, Rischin D, et al. Early FDG-PET imaging after radical radiotherapy for nonsmall-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 2004; 60: 412-18.
7. Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 2006; 101: 147-51. doi: 10.1016/j.ygyno.2005.10.005
8. Bollineni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM. Residual 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys 2012; 83: e551-5.
9. Oh D, Lee JE, Huh SJ, Park W, Nam H, Choi JY, et al. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 2013; 87: 549-54.
10. Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, et al. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys 2012; 82: 548-53. doi: 10.1016/j.ijrobp.2010.11.050
11. Kidd EA, Thomas M, Siegel BA, Dehdashti F, Grigsby PW. Changes in cervical cancer FDG uptake during chemoradiation and association with response. Int J Radiat Oncol Biol Phys 2013; 85: 116-22. doi: 10.1016/j.ijrobp.2012.02.056
12. van Loon J, Offermann C, Ollers M, van Elmpt W, Vegt E, Rahmy A, et al. Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study. Radiother Oncol 2011; 99: 172-5.
13. Petit SF, Aerts HJ, van Loon JG, Offermann C, Houben R, Winkens B, Ollers MC, et al. Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study. Radiother Oncol 2009; 91: 393-8. doi: 10.1016/j.radonc.2009.02.020
14. Hicks RJ, MacManus MP, Matthews JP, Hogg A, Binns D, Rischin D, et al. Early FDG-PET imaging after radical radiotherapy for nonsmall-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 2004; 60: 412-18.
15. Hicks RJ. Role of 18F-FDG PET in assessment of response in non-small cell lung cancer. J Nucl Med 2009; 50(Suppl. 1): 31-42S. doi: 10.2967/jnumed.108.057216
16. Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 2006; 47: 14-22.
17. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG. Granton P, et al. Radiomics: extracting more informationfrom medical images using advanced feature analysis. Eur J Cancer 2012; 48: 441-6. doi: 10.1016/j.ejca.2011.11.036
18. Materka A, Strzelecki M. Texture analysis methods - a review. COST B11 report. Brussels, Belgium: Technical University of Lodz, Institute of Electronics; 1998.
19. O'Connor JP, Rose CJ, Jackson A, Watson Y, Cheung S, Maders F, et al. DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer 2011; 105: 139-45. doi: 10.1038/bjc.2011.191
20. Hayano K, Lee SH, Yoshida H, Zhu AX, Sahani DV. Fractal analysis of CT perfusion images for evaluation of antiangiogenic treatment and survival in hepatocellular carcinoma. Acad Radiol 2014; 21: 654-60. doi: 10.1016/j.acra.2014.01.020
21. Chicklore S, Goh V, Siddique M, Roy A,Marsden PK, Cook GJ. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging 2013; 40: 133.
22. Haralick RM, Shanmugam K, Dinstein I. Textural features for image classification. IEEE Trans Syst Man Cybern 1973; 3: 610-21.
23. Galloway MM. Texture analysis using grey level run lengths. Comput Graph Imaging 1974; 4: 172-9.
24. Amadasun M, King R. Textural features corresponding to textural properties. IEEE Trans Syst Man Cybern 1989; 19: 1264-74.
25. Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. Radiomics: the process and the challenges. Magn Reson Imaging 2012; 30: 1234-48. doi: 10.1016/j.mri.2012.06.010
26. Vasconcelos V, Silva JS, Marques L, Barroso J. Statistical textural features for classification of lung emphysema in CT images: a comparative study. Proceedings of the 5th Iberian Conference on Information Systems and Technologies (CISTI); 16-19 June 2010; Santiago de Compostela, Spain. Piscataway, NJ; IEEE, 2010. pp. 1-5.
27. Xu Y, Sonka M, Mclennan G, Guo J, Hoffman EA. MDCT-based 3-D texture classification of emphysema and early smoking related lung pathologies. IEEE Trans Med Imaging 2006; 25: 464-75. doi: 10.1109/TMI.2006.870889
28. Gibbs P, Turnbull LW. Textural analysis of contrast-enhanced MR images of the breast. Magn Reson Med 2003; 50: 92-8. doi: 10.1002/mrm.10496
29. Yu H, Caldwell C, Mah K, Mozeg D. Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans Med Imaging 2009; 28: 374-83.
30. Eliat P, Olivié D, Saïkali S, Carsin B, Saint-Jalmes H, de Certaines JD. Can dynamic contrast-enhanced magnetic resonance imaging combined with texture analysis differentiate malignant glioneuronal tumors from other glioblastoma? Neurol Res Int 2012; 2012: 195176.
31. Ganeshan B, Miles KA, Young RC, Chatwin CR. Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival. Acad Radiol 2007; 14: 1520-30. doi: 10.1016/j.acra.2007.06.028
32. Ganeshan B, Miles KA, Young RC, Chatwin CR. Hepatic entropy and uniformity: additional parameters that can potentially increase the effectiveness of contrast enhancement during abdominal CT. Clin Radiol 2007; 62: 761-8.
33. Miles KA, Ganeshan B, Griffiths MR, Young RC, Chatwin CR. Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 2009; 250: 444-52. doi: 10.1148/radiol.2502071879
34. Ganeshan B, Miles KA, Young RC, Chatwin CR. Texture analysis in non-contrast enhanced CT: impact of malignancy on texture in apparently disease-free areas of the liver. Eur J Radiol 2009; 70: 101-10. doi: 10.1016/j.ejrad.2007.12.005
35. Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA. Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer imaging 2010; 10: 137-43.
36. Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 2012; 22: 796-802. doi: 10.1007/s00330-011-2319-8
37. Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 2012; 67: 157-64. doi: 10.1016/j.crad.2011.08.012
38. Ganeshan B, Goh V, Mandeville HC, Ng QS, Hoskin PJ, Miles KA. Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 2013; 266: 326-36. doi: 10.1148/radiol.12112428
39. Yip C, Landau D, Kozarski R, Ganeshan B, Thomas R, Michaelidou A, et al. Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. Radiology 2014; 270: 141-8.
40. Win T, Miles KA, Janes SM, Ganeshan B, Shastry M, Endozo R, et al. Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer. Clin Cancer Res 2013; 19: 3591-9. doi: 10.1158/1078-0432.CCR-12-1307
41. Vaidya M, Creach KM, Frye J, Dehdashti F, Bradley JD, El Naqa I. Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. Radiother Oncol 2012; 102: 239-45. doi: 10.1016/j.radonc.2011.10.014
42. Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes. Acta Oncol 2013; 52: 910-18.
43. Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 2014; 41: 033502. doi: 10.1118/1.4866219
44. El Naqa I, Grigsby P, Apte A, Kidd E, Donnelly E, Khullar D, et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 2009; 42: 1162-71. doi:10.1016/j.patcog.2008.08.011
45. Tixier F, Le Rest CC, Hatt M, Albarghach N, Pradier O, Metges JP, et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 2011; 52: 369-78.
46. Tixier F, Hatt M, Le Rest CC, Le Pogam A, Corcos L, Visvikis D. Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 2012; 53: 693-700. doi: 10.2967/jnumed.111.099127
47. Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, et al. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 2013; 54: 19-26. doi: 10.2967/jnumed.112.107375
48. Cook GJR, Siddique M, Taylor BP, Yip C, Chicklore S, Goh V. Radiomics in PET: principles and applications. Clin Transl Imaging 2014; 2: 269-276. doi 10.1007/s40336-014-0064-0.
49. Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, et al. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. Int J Radiat Oncol Biol Phys 2012; 83: 972-9.
50. Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000; 12: 1027-33.
51. Ahmed A, Gibbs P, Pickles M, Turnbull L. Texture analysis in assessment and prediction of chemotherapy response in breast cancer. J Magn Reson Imaging 2013; 38: 89-101. doi: 10.1002/jmri.23971
52. Henriksson E, Kjellen E, Wahlberg P, Ohlsson T, Wennerberg J, Brun E. 2-deoxy-2- F-18fluoro-D-glucose uptake and correlation to intratumoral heterogeneity. Anticancer Res 2007; 27: 2155-9.
53. van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA, et al. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 2011; 38: 1636-47. doi: 10.1007/s00259-011-1845-6
54. Teo BK, Seo Y, Bacharach SL, Carrasquillo JA, Libutti SK, Shukla H, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007; 48: 802-10. doi: 10.2967/jnumed.106.035576
55. Tohka J, Reilhac A. A Monte Carlo study of deconvolution algorithms for partial volume correction in quantitative PET. IEEE Nucl Sci Symp Conf 2006; 6: 3339-45.
56. Geets X, Lee JA, Bol A, Lonneux M, Grégoire V. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 2007; 34: 1427-38. doi: 10.1007/s00259-006-0363-4
57. Brooks FJ, Grigsby PW. The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake. J Nucl Med 2014; 55: 37-42. doi: 10.2967/jnumed.112.116715
58. Aristophanous M, Berbeco RI, Killoran JH, Yap JT, Sher DJ, Allen AM, et al. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning. Int J Radiat Oncol Biol Phys 2012; 82: e99-105. doi: 10.1016/j.ijrobp.2010.12.060
59. Cai J, Chang Z, Wang Z, Paul Segars W, Yin FF. Four-dimensional magnetic resonance imaging (4D-MRI) using image-based respiratory surrogate: a feasibility study. Med Phys 2011; 38: 6384-94. doi: 10.1118/1.3658737
60. Tryggestad E, Flammang A, Han-Oh S, Hales R, Herman J, McNutt T, et al. Respirationbased sorting of dynamic MRI to derive representative 4D-MRI for radiotherapy planning. Med Phys 2013; 40: 051909. doi: 10.1118/1.4800808
61. Tokuda J, Morikawa S, Haque HA, Tsukamoto T, Matsumiya K, Liao H, et al. Adaptive 4D MR imaging using navigatorbased respiratory signal for MRI-guided therapy. Magn Reson Med 2008; 59: 1051-61. doi: 10.1002/mrm.21436
62. Blackall JM, Ahmad S, Miquel ME, McClelland JR, Landau DB, Hawkes DJ. MRI-based measurements of respiratory motion variability and assessment of imaging strategies for radiotherapy planning. Phys Med Biol 2006; 51: 4147-69. doi: 10.1088/0031-9155/51/17/003
63. Ng F, Kozarski R, Ganeshan B, Goh V. Assessment of tumor heterogeneity by CT texture analysis: can the largest crosssectional area be used as an alternative to whole tumor analysis? Eur J Radiol 2013; 82: 342-8. doi: 10.1016/j.ejrad.2012.10.023
64. Mahmoud-Ghoneim D, Toussaint G, Constans JM, de Certaines JD. Three dimensional texture analysis in MRI: a preliminary evaluation in gliomas. Magn Reson Imaging 2003; 21: 983-7.
65. Xu Y, Sonka M, McLennan G, Guo J, Hoffman E. Sensitivity and specificity of 3-D texture analysis of lung parenchyma is better than 2-D for discrimination of lung pathology in Stage 0 COPD. Proc SPIE Med Imaging; 2005; 5746: 474-485.
66. Chen W, Giger ML, Li H, Bick U, Newstead GM. Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn Reson Med 2007; 58: 562-71. doi: 10.1002/mrm.21347
67. Leijenaar RT, Carvalho S, Velazquez ER, van Elmpt WJ, Parmar C, Hoekstra OS, et al. Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and interobserver variability. Acta Oncol 2013; 52: 1391-7. doi: 10.3109/0284186X.2013.812798
68. Klein S, van der Heide UA, Lips IM, van Vulpen M, Staring M, Pluim JP. Automatic segmentation of the prostate in 3D MR images by atlas matching using localized mutual information. Med Phys 2008; 35: 1407-17.
69. El Naqa I, Yang D, Apte A, Khullar D, Mutic S, Zheng J, et al. Concurrent multimodality image segmentation by active contours for radiotherapy treatment planning. Med Phys 2007; 34: 4738-49.
70. Chowdhury N, Toth R, Chappelow J, Kim S, Motwani S, Punekar S, et al. Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning. Med Phys 2012; 39: 2214-28. doi: 10.1118/1.3696376